Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
European Journal of Haematology|October 1, 1989
Idarubicin in combination with intermediate-dose cytarabine in the treatment of refractory or relapsed acute leukemiasA M Carella, E Pungolino, G Piatti, et al.
Haematologica|March 1, 1989
Hairy cell leukemia. A therapeutical updateE E Damasio, G Pagnucco, M Federico, et al.
Acta Haematologica|March 1, 1977
Peptichemio: A new oncolytic drug in combination with vincristine and prednisolone in the treatment of non-Hodgkin lymphomasA M Carella, A Bacigalupo, G Santini, et al.
British Journal of Haematology|December 1, 1994
Prognostic value of serum IL-10 and soluble IL-2 receptor levels in aggressive non-Hodgkin's lymphomaR Stasi, P L Zinzani, P Galieni, et al.
Lupus|April 1, 1996
Accuracy of 133-xenon regional cerebral blood flow and quantitative electroencephalography in systemic lupus erythematosusF Nobili, G Rodriguez, A Arrigo, et al.
British Journal of Haematology|May 1, 1989
Human lymphoblastoid interferon as initial therapy in hairy cell leukaemia: a multicentre study in non-splenectomized patients. Italian Cooperative Group for Hairy Cell LeukemiaM Federico, T Chisesi, F Lauria, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1994
Impact of interferon at induction chemotherapy and maintenance treatment for multiple myeloma. Preliminary results of a multicenter study by the Italian non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG)G Capnist, M Vespignani, M Spriano, et al.
Leukemia & Lymphoma|April 1, 1994
Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group (ICGHCL). Italian Cooperative Group for Hairy Cell LeukemiaA Frassoldati, T Lamparelli, M Federico, et al.
Cancer|December 15, 1984
High-dose chemotherapy and non-frozen autologous bone marrow transplantation in relapsed advanced lymphomas or those resistant to conventional chemotherapyA M Carella, G Santini, D Giordano, et al.
Bone Marrow Transplantation|August 1, 1991
Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocolA M Carella, P Carlier, A Congiu, et al.
Pageof 5